| Issue Date | Title | Author(s) |
| 2021 | Advantage of co-culture strategy for targeted cancer treatment and in vitro studies | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Dinçer İşoğlu, Sevil; Baran, Yusuf |
| 2021 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf |
| Jul-2019 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe |
| 28-Oct-2021 | HER2-targeted, degradable core cross-linked micelles for specific and dual pH-sensitive DOX release | Bayram, Nazende Nur; Ulu, Gizem Tuğçe ; Topuzoğulları, Murat; Baran, Yusuf ; Dinçer İşoğlu, Sevil |
| Apr-2022 | Peptıde targeted core cross-lınked mıcelles for dox delıvery to HER2 expressıng cancer cells | Bayram, Nazende Nur; Ulu, Gizem Tuğçe ; Gürdap, Seda; İşoğlu, İsmail Alper; Baran, Yusuf ; Dinçer İşoğlu, Sevil |
| 2022 | The role of miRNA in cancer: Pathogenesis, diagnosis, and treatment | Uzuner, Erez; Ulu, Gizem Tuğçe ; Gürler, Sevim Beyza; Baran, Yusuf |
| 2020 | Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia | Koca, Duygu; Hastar, Nurcan; Engür, Selin; Kiraz, Yağmur ; Ulu, Gizem Tuğçe ; Çekdemir, Demet; Baran, Yusuf |
